Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats

Pharmacology

Volumn 71, Issue 2, 2004, Pages 66-72

  Calama, E ^a   Moran A ^a   Ortiz De Urbina, A V ^a   Martin M L ^a   San Roman L ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

5 HT 2C receptors; 5 HT2A receptors; 5 Hydroxytryptamine; Hindquarter blood flow; Serotonin; Spontaneously hypertensive rat; Vasoconstrictor effect

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; ENALAPRIL; INDOMETACIN; PRAZOSIN; PROPRANOLOL; RITANSERIN; SEROTONIN; SEROTONIN 2 AGONIST; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; INDOLES; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; PERFUSION; PIPERAZINES; PRAZOSIN; PYRIDINES; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN, 5-HT2; REGIONAL BLOOD FLOW; RITANSERIN; SEROTONIN; SEROTONIN AGONISTS; SPIPERONE; THIOPHENES; VASOCONSTRICTION;

EID: 2342568467     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076942     Document Type: Article

References (30)

1. Fozard JR: Neuronal 5-HT receptors in the periphery. Neuropharmacology 1984;23:1473-1486.
2. Saxena PR, Bolt GR, Dhasmana KM: Serotonin agonists and antagonists in experimental hypertension. J Cardiovasc Pharmacol 1987;10:S12-S18.
3. Bagdy G, Szemeredi K, Hill JL, Murphy DL: The serotonin agonist, m-chlorophenyl-piperazine, markedly increases levels of plasma catecholamines in the conscious rat. Neuropharmacology 1988;27:975-980.
4. Bagdy G, Szemeredi K, Murphy DL: Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propyl-amino) tetralin (8-OH DPAT) in conscious rats. J Pharm Pharmacol 1989;41:270-272.
5. Vanhoutte PM: Endothelium dependent contractions in arteries and veins. Blood Vessels 1987;24:141-144.
6. Vanhoutte PM: Cardiovascular effects of serotonin. J Cardiovasc Pharmacol 1987;10:S8-S11.
7. Villalón CM, Terrón J, Hong E, Saxena PR: Efectos cardiovasculares de agonistas y antagonistas de los receptores a la serotonina (Parte 1). Arch Inst Cardiol Mex 1993;63:441-447.
8. Vanhoutte PM: Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin? J Cardiovas Pharmacol 1985;7:S105-S109.
9. Vanhoutte PM: Platelet-derived serotonin, the endothelium and cardiovascular disease. J Cardiovasc Pharmacol 1991;17:S6-S12.
10. 2 receptor activation. Eur J Pharmacol 1997;330:205-211.
11. 2C receptor activation. Eur J Pharmacol 2000;401:221-227.
12. Warner TD: Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: Comparison of their vasoconstrictor and vasodilator responses to agonists. Br J Pharmacol 1990;99:427-433.
13. Calama E, Fernández MM, Morán A, Martín ML, San Román L: Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 2002;366:110-116.
14. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Búhler FR: Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 1988;11:573-578.
15. Ibarra M, Meneses A, Ransanz V, Castillo C, Hong E: Changes in endothelium-dependent vascular responses associated with spontaneous hypertension and age rats. Arch Med Res 1995;26:S177-S183.
16. Salomone S, Morel A, Godfrain T: Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar, Kyoto and stroke-prone rats. Br J Pharmacol 1997;121:1051-1058.
17. Cheng JB, Shibata S: Pressor response to 5-hydroxytryptamine, norepinephrine and KCl in the perfused hindquarter preparation from the spontaneously hypertensive rat. J Pharmacol Exp Ther 1980;214:488-495.
18. Okada M, Bunag RD: Selective enhancement in SHR of hypotension and bradycardia caused by NTS-injected serotonin. Am J Physiol 1994;266:R599-R605.
19. Deggrell SA: Increase in affinity and loss of 5-hydroxytryptamine2A- receptor reserve for 5-hydroxytryptamine on the aorta of spontaneously hypertensive rats. J Auton Pharmacol 1995;15:371-377.
20. Gulati A, Arora RC, Crayton J: Central serotonergic uptake mechanisms in hypertensive rats: Effects of clonidine and centhaquin. Eur J Pharmacol 1993;231:151-156.
21. Boston PC, Hodgson WC: Changes in reactivity towards 5-hydroxytryptamine in the renal vasculature of the diabetic spontaneously hypertensive rat. J Hypertens 1997;15:769-774.
22. Brody MJ, Shaffer RA, Dixon RL: A method for the study of peripheral vascular response in the rat. J Appl Physiol 1963;18:645-647.
23. Prewitt RL, Reilly CK, Wang DH: Pressure-flow curves reflect arteriolar responses in perfused rat hindquarters. Hypertension 1994;23:223-228.
24. Nishimura Y, Suzuki A: Enhanced contractile responses mediated by different 5-HT receptor subtypes in basilar arteries, superior mesenteric arteries and thoracic aortas from strokeprone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995;22:S99-S101.
25. Rubany GM, Kauser K, Gräser T: Effect of cilazapril and indomethacin on endothelial dysfunction in the aortas of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;22:S23-S30.
26. Yokota Y, Imaizumi Y, Asano M, Matsuda T, Watanabe M: Endothelium-derived relaxing factor released by 5-HT: Distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br J Pharmacol 1994;113:324-330.
27. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA: International Union of Pharmacology classification of receptors of 5-hydroxy-tryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
28. 2B receptor agonist, BW 723C86, on the three rat models of anxiety. Br J Pharmacol 1996;117:1443-1448.
29. Kennett GA, Ainsworth K, Trail B, Blackburn TP: BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 1997;36:233-239.
30. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-554.